Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose-induced hypertensive rat model

被引:58
作者
Juan, CC
Fang, VS
Hsu, YP
Huang, YJ
Hsia, DB
Yu, PC
Kwok, CF
Ho, LT
机构
[1] Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan
[2] Vet Gen Hosp, Dept Internal Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Dept Physiol, Taipei 112, Taiwan
关键词
endothelin-1; endothelin-A receptor; hyperinsulinemia; BQ-610; hypertension; fructose;
D O I
10.1097/00004872-199816120-00010
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To examine the temporal relationship between hyperinsulinemia and hypertension in the fructose-hypertensive rat model and to study the function of endothelin-1 (ET-1) in fructose-induced hypertension. Design Since ET-1 induces insulin resistance in conscious rats, we tested the hypothesis that both hyperinsulinemia and hypertension developed in the fructose-hypertensive rat model might be the sequelae of an elevated tissue content of ET-1 and ETA receptors. Materials and methods Systolic hypertension was induced within 3 weeks in male Sprague-Dawley rats fed on a fructose-rich diet. After continual monitoring of blood pressure and plasma insulin concentrations, the animals were killed at the end of experiment to determine plasma levels of ET-1, the contractile response of aortic rings to ET-1, and ET-1 and ETA receptor gene expressions. in a separate experiment, BQ-610 was administered to lower the effect of ET-1 in rats with fructose-induced hypertension. Results Compared with control rats given normal chow, the fructose-fed rats developed systolic hypertension after 3 weeks of the diet (127 +/- 3.7 versus 110 +/- 5.5 mmHg, P< 0.01) and hyperinsulinemia both before (107.1 +/- 32.5 versus 48.5 +/- 14.3 pmol/I, P < 0.005) and after (96.6 +/- 63.7 versus 50.4 +/- 5.6 pmol/l, P< 0.05) they became hypertensive. Although plasma ET-1 levels did not differ between the rat groups, aortic ring contraction-concentration curves, indicating vessel contractility in response to ET-1, were significantly greater in these rats than in controls (F-1,F-72 = 12.34, P< 0.00077). Messenger RNA extracted from the tail arteries and blotted with both ET-1 and ETA probes showed that fructose-fed rats had greater ET-1 and ETA-receptor gene expression than control rats. Concomitant administration of BQ-610 to rats fed on a fructose diet significantly reduced the hypertension. Conclusions These findings suggest that elevated vascular expression of ET-1 and ETA receptor genes may mediate the development of hypertension and hyperinsulinemia in rats fed a fructose-rich diet. (C) Lippincott Williams & Wilkins.
引用
收藏
页码:1775 / 1782
页数:8
相关论文
共 49 条
  • [41] Effect of chronic endothelin blockade in hyperinsulinemic hypertensive rats
    Verma, S
    Bhanot, S
    McNeill, JH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (06): : H2017 - H2021
  • [42] VERMA S, 1994, J PHARMACOL EXP THER, V271, P1334
  • [43] WAGNER OF, 1992, J BIOL CHEM, V267, P16066
  • [44] SUGARS AND BLOOD-GLUCOSE CONTROL
    WOLEVER, TMS
    MILLER, JB
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 62 (01) : 212S - 227S
  • [45] INSULIN MODULATES CIRCULATING ENDOTHELIN-1 LEVELS IN HUMANS
    WOLPERT, HA
    STEEN, SN
    ISTFAN, NW
    SIMONSON, DC
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (08): : 1027 - 1030
  • [46] DETERMINATION OF IMMUNOREACTIVE ENDOTHELIN IN MEDIUM FROM CULTURED ENDOTHELIAL-CELLS AND HUMAN-PLASMA
    XUAN, YT
    WHORTON, AR
    SHEARERPOOR, E
    BOYD, J
    WATKINS, WD
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (01) : 326 - 332
  • [47] A NOVEL POTENT VASOCONSTRICTOR PEPTIDE PRODUCED BY VASCULAR ENDOTHELIAL-CELLS
    YANAGISAWA, M
    KURIHARA, H
    KIMURA, S
    TOMOBE, Y
    KOBAYASHI, M
    MITSUI, Y
    YAZAKI, Y
    GOTO, K
    MASAKI, T
    [J]. NATURE, 1988, 332 (6163) : 411 - 415
  • [48] THRESHOLD CONCENTRATIONS OF ENDOTHELIN-1 POTENTIATE CONTRACTIONS TO NOREPINEPHRINE AND SEROTONIN IN HUMAN ARTERIES - A NEW MECHANISM OF VASOSPASM
    YANG, ZH
    RICHARD, V
    VONSEGESSER, L
    BAUER, E
    STULZ, P
    TURINA, M
    LUSCHER, TF
    [J]. CIRCULATION, 1990, 82 (01) : 188 - 195
  • [49] YU JCM, 1995, J CARDIOVASC PHARM, V26, pS348